DJ001

CAS No. 2161305-12-8

DJ001( —— )

Catalog No. M32888 CAS No. 2161305-12-8

DJ001 is a highly specific, selective, and non-competitive protein tyrosine phosphatase σ (PTPσ) inhibitor with an IC50 of 1.43 μM, and it promotes the regeneration of hematopoietic stem cells.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 88 Get Quote
5MG 136 Get Quote
10MG 212 Get Quote
25MG 339 Get Quote
50MG 478 Get Quote
100MG 626 Get Quote
500MG 1251 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    DJ001
  • Note
    Research use only, not for human use.
  • Brief Description
    DJ001 is a highly specific, selective, and non-competitive protein tyrosine phosphatase σ (PTPσ) inhibitor with an IC50 of 1.43 μM, and it promotes the regeneration of hematopoietic stem cells.
  • Description
    DJ001 is a highly specific, selective and non-competitive protein tyrosine phosphatase-σ (PTPσ) inhibitor with an IC50 of 1.43 μM. DJ001 displays no inhibitory activity against other phosphatases, with only modest inhibitory activity against Protein Phosphatase 5. DJ001 promotes promote hematopoietic stem cell regeneration.
  • In Vitro
    DJ001 (5-1000 ng/mL; 3-7 days; BM KSL cells) treatment increases the percentages and numbers of BM KSL cells in culture compared with control cultures. DJ001 treatment also significantly increases the numbers of colony forming cells (CFCs) in 3?day culture of BM KSL cells. The BM KSL cells are irradiated with 300?cGy and placed in media (containing 20?ng/mL Thrombopoietin, 100?ng/mL stem cell factor (SCF), 50?ng/mL Flt3 ligand, TSF) with and without 1?μg/mL DJ001 for 3 days. DJ001 treatment increases recovery of BM CFCs and multipotent colony-forming unit–granulocyte erythroid monocyte megakaryocyte (CFU-GEMM) colonies compared with control cultures.Cell Viability Assay Cell Line:BM KSL cells Concentration:5 ng/mL, 10 ng/mL, 100 ng/mL, 1000 ng/mL Incubation Time:3 days or 7 days Result:Increased the percentages and numbers of BM KSL cells. Also significantly increased the numbers of colony forming cells (CFCs) in 3?day culture of BM KSL cells.
  • In Vivo
    DJ001 (5?mg/kg; subcutaneous injection; for 24 hours; female C57BL/6 mice) significantly decreases the percentage of apoptotic BM KSL cells in C57BL/6 mice at 24?h following 500?cGy TBI. DJ001 suppresses radiation-induced HSC apoptosis via activation of the RhoGTPase, RAC1, and induction of BCL-XL.Animal Model:Female C57BL/6 mice (8-10-week-old) irradiated with total body irradiation (TBI)Dosage:5?mg/kg Administration: Subcutaneous injection; for 24 hours Result:Significantly decreased the percentage of apoptotic BM KSL cells in C57BL/6 mice at 24?h following 500?cGy TBI.
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Phosphatase
  • Recptor
    Phosphatase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2161305-12-8
  • Formula Weight
    268.27
  • Molecular Formula
    C15H12N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 250 mg/mL (931.90 mM; Ultrasonic )
  • SMILES
    N(/C=C\C(=O)C1=CC=CC=C1)C2=CC(N(=O)=O)=CC=C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Zhang Y, et al. PTPσ inhibitors promote hematopoietic stem cell regeneration. Nat Commun. 2019 Aug 14;10(1):3667.?
molnova catalog
related products
  • Licoflavone A

    Licoflavone A is a natural product isolated from the roots of Glycyrrhiza uralensis.

  • KY-226

    KY-226 is a potent inhibitor of protein tyrosine phosphatase 1B (PTP1B)(IC50: 0.25 μM)

  • SHP099

    SHP099 free base is an effective, selective, orally bioavailable, and efficacious SHP2 inhibitor (IC50 =0.07 μM and p-ERK modulation in cells IC50 = 0.250 μM). SHP099 shows dose-dependent pathway inhibition and antitumor activity in xenograft models.